A cancer-causing chemical impurity found in Chantix has prompted a Class-action lawsuit against Pfizer. But the lawsuit has been dismissed without costs or attorneys’ fees. How did the lawsuit get dismissed? This article will explain how a lawsuit against Pfizer can be dismissed without costs. And what do you do if your lawsuit was dismissed? If your lawsuit was dismissed without attorneys’ fees, it may not be worth filing a Class-action lawsuit against Pfizer.
Chantix contains a cancer-causing chemical impurity
Pfizer, the maker of the anti-obesity medication Chantix, has voluntarily recalled certain lots of the drug following reports that it contains a cancer-causing chemical impurity. The chemical is nitrosamine, a naturally occurring molecule that has no known industrial use and is known to cause cancer in laboratory animals. While there was no immediate threat to patients taking Chantix, the recall was expanded and Pfizer paused its distribution of the drug.
In July of this year, Pfizer recalled some Chantix lots due to elevated levels of a nitrosamine chemical. N-nitroso-varenicline is known to cause cancer in humans when ingested in high enough doses over a long period. There is currently no conclusive evidence that Chantix causes cancer in humans, but the underlying problem is still worrying. The FDA has now approved generic Chantix and has urged consumers to avoid Chantix and buy generic.
Class-action lawsuit filed against Pfizer
In a recent ruling, a Florida court has thrown out a Chantix class-action lawsuit against Pfizer, arguing that the drug does not protect against cancer. Chantix has been linked to heart attack and stroke risks. While the drug is still on the market, it is known to cause gastrointestinal problems. The FDA approved Chantix in 2008 and it is prescribed to many people with hypertension and high cholesterol.
But the case against Pfizer is far from over. The class-action lawsuit filed against Pfizer was unsuccessful because the plaintiffs were unable to prove that Chantix was not an FDA-approved drug. In addition, there is no evidence that Pfizer knew that the drug was contaminated. Regardless, the case has a long way to go. If the case is successful, it could cost Pfizer billions of dollars.
Class-action lawsuit dismissed without costs or attorneys’ fees
The U.S. District Court for the Southern District of Illinois has dismissed a Chantix class-action lawsuit without costs or attorneys’ fees, after finding that the plaintiffs failed to state their claims enough. Plaintiffs had accused Pfizer of failing to warn about cancer-causing agents in the drug, and that these contaminants were contaminating the product. However, the court found that the plaintiffs failed to demonstrate that Pfizer knew the substance was contaminated with carcinogenic agents and would have avoided purchasing the product if they had known it.
The plaintiffs, in this case, were two former Chantix users who filed suit, Mary Allen and Roslyn Harris. They sued Pfizer over the recall of Chantix, a medication designed to help smokers quit smoking. However, the drug was recalled in June after the discovery of nitrosamine, a chemical that has been linked to cancer. Chantix is manufactured by Pfizer and contains nicotine derivatives, including varenicline. However, Pfizer has said that the drug contains “nitroso-varenicline,” another substance that has been flagged as a possible carcinogen.
A class-action lawsuit against Pfizer
A putative Chantix class-action lawsuit against Phizer has been filed by Plaintiff Juan Abreu. The drug was developed to combat nicotine addiction. However, the pharmaceutical giant filed a Motion to Change Venue. The company argues that a previous class-action lawsuit involving Chantix is pending in the Southern District of New York. In this regard, a separate California court has jurisdiction over the case.
The trial judge dismissed the Chantix class-action suit based on the plaintiffs’ failure to state their claims in the lawsuit. Plaintiffs could not show that the contaminated product was substantially different from the original drug, and Pfizer failed to inform them of its contamination level at the time of purchase. The plaintiffs’ failure to prove that Pfizer had an obligation to warn consumers about the contamination was the primary reason the court dismissed their claim.
Side effects of Chantix
There have been many reports of serious side effects associated with Chantix, which include heart problems and seizures. This drug is not used for serious psychiatric disorders, but it has been linked to several other problems. Some people have reported experiencing chest discomfort, difficulty breathing, and pain in the neck, back, and jaw. Some have also experienced abnormal behavior and skin problems while taking Chantix. The FDA is still investigating these effects.
Although the risks of these side effects are relatively low, some people have reported experiencing mood and behavior changes while taking CHANTIX. The list of side effects is not exhaustive, so contact your doctor if you experience any of these symptoms. If you do experience any of these effects, call your doctor or report them to the FDA. Side effects of Chantix include constipation, insomnia, sleep disorder, abnormal dreams, and nausea.